Firms Provided Third-Party, Nonclinical Premarket Testing; Agency Review Ongoing SILVER SPRING, Md., Sept. 11, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration issued warning letters to two Chinese nonclinical testing laboratories, citing both for laboratory oversight…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.